IPSC vs USB
Century Therapeutics Inc (IPSC) versus U.S. Bancorp (USB) — a side-by-side from cached financials, not a winner call.
Century Therapeutics Inc (IPSC) is a biotechnology company listed on US.
U.S. Bancorp (USB) is a banks - regional company listed on US.
Latest reported IPSC revenue for 2024-12-31 was $6.6M. Net income was -$126.6M. Revenue was up 194.8% from 2023-12-31 to 2024-12-31. IPSC currently screens at market cap $47.8M.
Latest reported USB revenue for 2025-12-31 was $28.66B. Net income was $7.57B. Revenue was up 4.4% from 2024-12-31 to 2025-12-31. USB currently screens at market cap $74.68B and trailing P/E 11.9.
IPSC currently screens at market cap $47.8M. USB currently screens at market cap $74.68B and trailing P/E 11.9.
Not investment advice. Open the IPSC and USB stock pages for the full models.
Not investment advice.